Inhibition of osteosarcoma lung metastases by {beta}-glucan and CD40 agonist is mediated by activation of macrophages and NK cells
Background
Osteosarcoma (OS) lung metastases remain a significant therapeutic challenge. Innate immune activation is a promising therapeutic approach. Innate immune agonists can modulate the tumor immune microenvironment and improve therapeutic respon…